HemaSource
PrivateLast Round
Buyout/LBO
Jul 20, 2017
Momentum
Top 1%
of companies Caplight tracks
Company Overview
HemaSource operates in Healthcare & Life Sciences and is based in Salt Lake City, Utah. Its latest recorded funding round was a Private Equity round in February 2010.
HemaSource is a healthcare logistics and medical supply company that provides medical consumables and proprietary inventory management software to plasma collection centers and other specialty ambulatory clinics.
Sector
Healthcare & Life Sciences
Verticals
Supply Chain, Pharma Supply Chain, Medical Devices, Logistics Software
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HemaSource Comparables
Compare HemaSource with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| McKesson | 74% | |
| Inventory Optimization Solutions | 70% | |
| InVita Healthcare Technologies | 70% |
For institutional investors. Book with your work email.
HemaSource Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Buyout/LBO | Jul 20, 2017 | ||||
| Buyout/LBO | Jul 24, 2014 | ||||
| Private Equity | Feb 1, 2010 |
For institutional investors. Book with your work email.
HemaSource Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ridgemont Equity Partners | Buyout/LBO |
| Graham Partners | Buyout/LBO |
| Peterson Partners | Private Equity |
| Housatonic Partners | Private Equity |
| Search Fund Partners | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased to 8, representing 89% of headcount.
- Oct 26, 2026
Open roles increased to 3, 2.3x the trailing average.
For institutional investors. Book with your work email.
HemaSource Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HemaSource's valuation, stock price, and market status.
Is HemaSource a public or private company?
HemaSource is a private company.
What is the current stock price of HemaSource?
HemaSource is a private company, so its shares have no public market price. Caplight tracks HemaSource's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HemaSource worth (valuation)?
Valuation information for HemaSource is not publicly available.
Can I buy HemaSource stock?
HemaSource shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HemaSource's last funding round?
HemaSource's most recent funding round was Buyout/LBO on July 20, 2017.
Who are the main investors in HemaSource?
Key investors in HemaSource include Ridgemont Equity Partners, Graham Partners, Housatonic Partners.
Will HemaSource IPO soon?
No public IPO plans have been announced for HemaSource.
How can I track HemaSource secondary market activity?
Caplight tracks bids, offers, and trades in HemaSource's shares on secondary markets.